Table 3.
Comparison of baseline demographics and clinical parameters of patients in Early Azathioprine (EAZ) versus Late Azathioprine (LAZ) groups
| Demographics | EAZ (n = 16) | LAZ (n = 17) | p value |
|---|---|---|---|
| N (%) or mean ± SD or median (range) | |||
| Gender | |||
| Males | 12 (54.5%) | 10 (45.5%) | 0.32 |
| Females | 4 (36.4%) | 7 (63.6%) | 0.38 |
| Race | |||
| Chinese | 7 (50%) | 7 (50%) | |
| Malay | 1 (16.7%) | 5 (83.3%) | |
| Indian | 6 (60%) | 4 (40%) | |
| Others | 2 (66.7%) | 1 (33.3%) | |
| Median Age at presentation in years and (range) | 11.5 (3–16) | 14 (4–17) | 0.18 |
| Clinical parameters | |||
| BMI z-score | −1.12 ± 0.9 | −1.5 ± 1.9 | 0.43 |
| PCDAI baseline | 32.1 ± 8.3 | 33.1 ± 10.3 | 0.77 |
| Hemoglobin g/dL | 11.3 ± 1.2 | 11.4 ± 1.7 | 0.80 |
| Albumin g/L | 30.6 ± 6.1 | 30.7 ± 8.6 | 0.97 |
| Platelets × 109 | 471 ± 175 | 456 ± 150 | 0.79 |
| ESR mm/h | 63.2 ± 37.5 | 41.3 ± 16.9 | 0.03 |
| CRP mg/L | 42.1 ± 40.3 | 47.1 ± 61.3 | 0.79 |
PCDAI Paediatric Crohn’s Disease Activity Index, BMI Body Mass Index, ESR Erthrocyte Sedimentation Rate, CRP C-Reactive Protein